Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Alkan, S.
Right arrow Articles by Ross, C. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alkan, S.
Right arrow Articles by Ross, C. W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 6:567-570, 1995
© 1995 European Society for Medical Oncology

research-article

Cyclin D1 protein expression in mantle cell lymphoma

S. Alkan1,, B. Schnitzer2, J. L. Thompson1, L. C. Moscinski1 and C. W. Ross2

1Department of Pathology, University of South Florida, H. Lee Moffitt Cancer Center Tampa, FL
2Department of Pathology, University of Michigan Hospitals Ann Arbor, MI, U.S.A

Correspondence to: Serhan Alkan, MD. Department of Pathology George Washington University 23rd Eye Street, NW Washington D.C. 20037 USA.

BACKGROUND: The t(ll;14)(ql3;q32) is a chromosomal abnormality usually associated with mantle cell (centrocytic) lymphomas, although it has occasionally been reported in other chronic lymphoproliferative disorders such as chronic lymphocytic leukemia, prolymphocytic leukemia, splenic lymphoma with villous lymphocytes, and multiple myeloma. This abnormality results in the translocation of the bcl-1 oncogene from chromosome 11 to the immunoglobulin heavy chain locus on chromosome 14. The bcl-1 oncogene is a member of the cyclin gene family, and high levels of cyclin Dl mRNA are consistently found in malignant B cell proliferations with t(ll;14).

PATIENTS AND METHODS: We examined cyclin D1 protein expression in 33 patients with low grade lymphoproliferative disorders and 2 patients with reactive hyperplasias by Western blot analysis using a polyclonal antibody.

RESULTS: 8/11 mantle cell lymphomas, 0/11 chronic lymphocytic leukemias, 0/4 hairy cell leukemias, 0/2 Sezary syn-drome, 0/2 monocytoid B-cell lymphomas, 0/3 follicular lymphomas, and 0/2 reactive hyperplasias had overexpres-sion of cyclin Dl. Cytogenetic analysis was performed in four cases of mantle cell lymphoma; three of these cases had the t(ll;14), one of which was hypotetraploid with two copies of t(ll; 14). Immunophenotypically, all cases of mantle cell lymphoma and chronic lymphocytic leukemia had coexpression ofCD5 and CD20.

CONCLUSION: Mantle cell lymphoma may be difficult to discriminate from chronic lymphocytic leukemia, a more indolent disease, on morphologic and immunophenotypic grounds. Our findings suggest that analysis of cyclin Dl protein expression may be helpful in differentiating mantle cell lymphomas from other low grade lymphoproliferative disorders.

cyclin D1, bcl-1, mantle cell lymphoma, centrocytic lymphoma, t(ll;14)(ql3;q32), low grade lymphoproliferative disorders


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Mayo Clin Proc.Home page
W. G. Morice, P. J. Kurtin, J. M. Hodnefield, T. D. Shanafelt, J. D. Hoyer, E. D. Remstein, and C. A. Hanson
Predictive Value of Blood and Bone Marrow Flow Cytometry in B-Cell Lymphoma Classification: Comparative Analysis of Flow Cytometry and Tissue Biopsy in 252 Patients
Mayo Clin. Proc., July 1, 2008; 83(7): 776 - 785.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.